OBSEGONE

Live / Registered — Registered (as of 22 Sept 2026)

What this means for you

Registered since 22 Sept 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 22 Sept 2032: the §71 affidavit of use).

Record

Serial number
79435559
Registration number
8445773
Mark type
Stylized text
Filed
23 Apr 2025
Published for opposition
04 Aug 2026
Registered
22 Sept 2026
Next maintenance filing
§71 affidavit of use, due by 22 Sept 2032 (grace period to 22 Mar 2033)
Attorney of record
John H. Mutchler

Goods and services

  • Class 005 — Pharmaceuticals: Drugs for medical purposes, namely, medical preparations for the treatment of diabetes, obesity, Alzheimer's disease, metabolic dysfunction-associated steatohepatitis (MASH), and metabolic dysfunction-associated steatotic liver disease (MASLD); medical preparation for treating alcoholic fatty liver; pharmaceutical preparations for the treatment of obesity; pharmaceutical preparations for the treatment of alzheimer's disease; herbal tea for medical purposes; injectable medicinal solutions, namely, injectable pharmaceuticals for the treatment of diabetes, obesity, Alzheimer's disease, metabolic dysfunction-associated steatohepatitis (MASH), and metabolic dysfunction-associated steatotic liver disease (MASLD); slimming pills; appetite suppressant pills; pharmaceutical preparations for the treatment of diabetes, obesity, Alzheimer's disease, metabolic dysfunction-associated steatohepatitis (MASH), and metabolic dysfunction-associated steatotic liver disease (MASLD); cardiovascular pharmaceuticals for medical use; medicines for human purposes, namely, medicinal preparations for the treatment of diabetes, obesity, Alzheimer's disease, metabolic dysfunction-associated steatohepatitis (MASH), and metabolic dysfunction-associated steatotic liver disease (MASLD); appetite suppressants for medical purposes; biological preparations for medical purposes for the treatment of diabetes, obesity, Alzheimer's disease, metabolic dysfunction-associated steatohepatitis (MASH), and metabolic dysfunction-associated steatotic liver disease (MASLD); medical preparations for slimming purposes; medical preparation for treating diabetes; slimming tea for medical purposes; antidiabetic pharmaceuticals; antidiabetic preparation; cardiovascular pharmaceutical preparations; lipotropic factor preparation; dietetic supplements adapted for medical use; diabetic bread adapted for medical use; dietetic beverages featuring fruit juices with pulp adapted for medical purposes, for use by diabetic patients

Owner

Prosecution history

  • 22 Sept 2026 — REGISTERED-PRINCIPAL REGISTER
  • 04 Aug 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 04 Aug 2026 — PUBLISHED FOR OPPOSITION
  • 29 Jul 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 02 Jul 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
  • 02 Jul 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 02 Jul 2026 — EXAMINER'S AMENDMENT ENTERED
  • 02 Jul 2026 — EXAMINERS AMENDMENT E-MAILED
  • 02 Jul 2026 — EXAMINERS AMENDMENT -WRITTEN
  • 03 Jun 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 03 Jun 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 03 Jun 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 01 Jan 2026 — REFUSAL PROCESSED BY IB
  • 17 Dec 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
  • 17 Dec 2025 — REFUSAL PROCESSED BY MPU

View this trademark record on Rightsy